4.6 Article

Protein composition of plasminogen activator inhibitor type 1-derived endothelial microparticles

Journal

SHOCK
Volume 29, Issue 4, Pages 504-511

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/SHK.0b013e3181454898

Keywords

EMP; microparticles; endothelial cells; proteome; PAI-1

Funding

  1. NHLBI NIH HHS [R01-HV28182, HL71412, HL61417, HL081139] Funding Source: Medline

Ask authors/readers for more resources

Endothelial microparticles (EMPs) are small vesicles released from the plasma membrane of endothelial cells in response to cell injury, apoptosis, or activation. Low levels of MPs are shed into the blood from the endothelium, but in some pathologic states, the number of EMPs is elevated. The mechanism of MP formation and the wide-ranging effects of elevated EMPs are poorly understood. Here, we report the protein composition of EMPs derived from human umbilical cord endothelial cells stimulated with plasminogen activator inhibitor type 1 (PAI-1). Two-dimensional gel electrophoresis followed by mass spectrometry identified 58 proteins, of which some were verified by Western blot analysis. Gene Ontology database searches revealed that proteins identified on PAI-1-derived EMPs are highly diverse. Endothelial microparticles are composed of proteins from different cellular components that exhibit multiple molecular functions and are involved in a variety of biological processes. Important insight is provided into the generation and protein composition of PAI-1-derived EMPs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available